Vertex Pharmaceuticals (VRTX) Convertible Debt (2010 - 2013)

Vertex Pharmaceuticals' Convertible Debt history runs 4 years deep, the most recent figure standing at $400.0 million for Q1 2013.

• In Q1 2013, Convertible Debt changed 0.0% year-over-year to $400.0 million; the TTM figure through Mar 2013 stood at $400.0 million (changed 0.0% YoY), while the FY2012 annual figure was $400.0 million, changed 0.0% from the prior year.
• Convertible Debt was $400.0 million for Q1 2013 at Vertex Pharmaceuticals, roughly flat from $400.0 million in the prior quarter.
• In the past five years, Convertible Debt ranged from a high of $400.0 million in Q3 2010 to a low of $32.1 million in Q1 2010.
• Historically, Convertible Debt has averaged $366.6 million across 4 years, with a median of $400.0 million in 2010.
• Biggest YoY gain for Convertible Debt was 1146.11% in 2011; the steepest drop was 0.0% in 2011.
• A 4-year view of Convertible Debt shows it stood at $400.0 million in 2010, then changed by 0.0% to $400.0 million in 2011, then changed by 0.0% to $400.0 million in 2012, then changed by 0.0% to $400.0 million in 2013.
• The last three Convertible Debt figures came in at $400.0 million (Q1 2013), $400.0 million (Q4 2012), and $400.0 million (Q3 2012), per Business Quant data.